OKYO

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

OKYO Pharma Ltd ADR

NASDAQ | OKYO

2.39

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 24, 2025)

$89.89M

Market Cap

-

P/E Ratio

-0.12

EPS

$3.34

52 Week High

$0.90

52 Week Low

HEALTHCARE

Sector

OKYO Chart

Recent Chart
Price Action

OKYO Technicals

Tags:

OKYO Earnings

Yearly Income Statement (As of Mar 31, 2025)

Field Value (USD)
Gross Profit -$2.6K
Total Revenue $0
Cost Of Revenue $2.6K
Costof Goods And Services Sold $2.6K
Operating Income -$7.2M
Selling General And Administrative -
Research And Development $2.3M
Operating Expenses $7.2M
Investment Income Net -
Net Interest Income -$878K
Interest Income $5.5K
Interest Expense $884K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.6K
Income Before Tax -$8M
Income Tax Expense -$3.3M
Interest And Debt Expense -
Net Income From Continuing Operations -$4.7M
Comprehensive Income Net Of Tax -
Ebit -$7.1M
Ebitda -$7.1M
Net Income -$4.7M

Revenue & Profitability

Earnings Performance

OKYO Financials

yearly Balance Sheet (As of Mar 31, 2025)

Field Value (USD)
Total Assets $3.7M
Total Current Assets $3.7M
Cash And Cash Equivalents At Carrying Value $1.6M
Cash And Short Term Investments $1.6M
Inventory -
Current Net Receivables $1.9M
Total Non Current Assets $2K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $225K
Other Non Current Assets -
Total Liabilities $9.2M
Total Current Liabilities $9.2M
Current Accounts Payable $7.9M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $1.3M
Other Non Current Liabilities -
Total Shareholder Equity -$5.5M
Treasury Stock -
Retained Earnings -$143M
Common Stock $147M
Common Stock Shares Outstanding $39M

yearly Cash Flow (As of Mar 31, 2025)

Field Value (USD)
Operating Cashflow -$1.8M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2.6K
Capital Expenditures $1.2K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$1.2K
Cashflow From Financing $2.7M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$8M

yearly Income Statement (As of Mar 31, 2025)

Field Value (USD)
Gross Profit -$2.6K
Total Revenue $0
Cost Of Revenue $2.6K
Costof Goods And Services Sold $2.6K
Operating Income -$7.2M
Selling General And Administrative -
Research And Development $2.3M
Operating Expenses $7.2M
Investment Income Net -
Net Interest Income -$878K
Interest Income $5.5K
Interest Expense $884K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.6K
Income Before Tax -$8M
Income Tax Expense -$3.3M
Interest And Debt Expense -
Net Income From Continuing Operations -$4.7M
Comprehensive Income Net Of Tax -
Ebit -$7.1M
Ebitda -$7.1M
Net Income -$4.7M

OKYO News

OKYO Profile

OKYO Pharma Ltd ADR Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

OKYO Pharma Ltd ADR is a preclinical biopharmaceutical company based in London, UK, specializing in the development of innovative therapies for inflammatory eye diseases and ocular pain. The company is leveraging advanced research to address significant unmet medical needs in the ophthalmology sector. With a focused pipeline and a commitment to innovation, OKYO is positioned to potentially transform the landscape of ocular therapeutics, offering promising solutions for patients suffering from debilitating eye conditions.

BYND
-23.06%
$2.18
WGRX
+185.43%
$1.14
VHAI
-50.00%
$0.00
TOVX
+0.87%
$0.34
YYAI
-14.98%
$0.07
VIVK
+11.91%
$0.29
F
+12.15%
$13.84
YDKG
-15.04%
$0.06
ASST
+27.28%
$1.10
INTC
+0.31%
$38.28
BURU
+17.26%
$0.40
CENN
-0.74%
$0.21
DVLT
+52.00%
$3.42
CGBS
-39.47%
$0.03
NVDA
+2.25%
$186.26
BITF
+10.68%
$4.61
TSLA
-3.39%
$433.72
AAL
+7.90%
$13.78
DNN
+2.93%
$2.81
CJET
+27.98%
$0.11
RGTI
-1.90%
$38.84
NEUP
+54.07%
$6.24
ADTX
-28.06%
$0.21
PLUG
+2.43%
$2.95
T
+2.11%
$25.14
RIG
+0.25%
$3.90
SCNX
-39.61%
$1.57
NOK
+2.10%
$6.30
AMD
+7.63%
$252.92
QBTS
+5.11%
$32.65
AXDX
-61.36%
$0.03
ABEV
-0.90%
$2.19
GPUS
+4.19%
$0.40
WTO
-7.14%
$0.06
RF
+1.95%
$24.57
CAN
+7.38%
$1.89
LAES
+22.55%
$7.01
SOFI
+3.31%
$29.01
NEHC
+48.35%
$5.86
NUAI
+48.35%
$5.86
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
GRAB
+2.27%
$5.85
TLRY
+0.67%
$1.49
QS
+14.73%
$16.82
ADAP
-7.57%
$0.06
SNAP
+1.01%
$7.95
CIFR
+19.73%
$20.66
AIRE
-22.42%
$0.76
ETHD
-3.52%
$3.83
JOBY
+2.93%
$16.13
ACHR
+3.48%
$11.29
IONZ
-4.02%
$3.82
RMBL
+60.50%
$3.21
RXRX
+5.41%
$6.04
BAC
+1.56%
$52.57
AMZN
+1.41%
$224.21
NIO
+0.14%
$6.90
AAPL
+1.24%
$262.82
ADD
-25.47%
$0.05
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
BTBT
+5.10%
$3.91
RR
+12.17%
$6.08
AMC
-1.46%
$2.69
NVTS
+3.37%
$14.07
SRM
+53.27%
$10.30
PLTR
+2.29%
$184.63
CLOV
+19.37%
$3.82
UUUU
+0.51%
$21.37
BTG
-0.38%
$5.21
DFLI
+13.27%
$1.28
RVPH
+18.99%
$0.67
BBD
0.00%
$3.35
MARA
+1.66%
$19.54
KDLY
+5.66%
$0.84
NAKA
+5.66%
$0.84
APLD
+0.14%
$33.43
CUTR
-10.19%
$0.09
PBR
-0.84%
$11.74
WU
+10.19%
$8.97
GOOGL
+2.70%
$259.92
SOUN
-1.42%
$17.98
WLGS
-5.57%
$0.04
RIVN
-0.84%
$12.98
IONQ
+1.56%
$60.30
VZ
+1.09%
$38.82
PFE
+0.36%
$24.76
WULF
+6.44%
$13.71
LAZR
+31.36%
$2.22
ETWO
0.00%
$3.30
RGTZ
+3.08%
$15.36
SKYQ
+9.15%
$0.50
MU
+5.95%
$219.02
JBLU
0.00%
$4.57
SMCI
+0.77%
$48.29
CLSK
+9.59%
$19.36
WBD
-0.47%
$21.15
LUMN
+3.85%
$8.09
HOOD
+4.06%
$139.79
BYND
-23.06%
$2.18
WGRX
+185.43%
$1.14
VHAI
-50.00%
$0.00
TOVX
+0.87%
$0.34
YYAI
-14.98%
$0.07
VIVK
+11.91%
$0.29
F
+12.15%
$13.84
YDKG
-15.04%
$0.06
ASST
+27.28%
$1.10
INTC
+0.31%
$38.28
BURU
+17.26%
$0.40
CENN
-0.74%
$0.21
DVLT
+52.00%
$3.42
CGBS
-39.47%
$0.03
NVDA
+2.25%
$186.26
BITF
+10.68%
$4.61
TSLA
-3.39%
$433.72
AAL
+7.90%
$13.78
DNN
+2.93%
$2.81
CJET
+27.98%
$0.11
RGTI
-1.90%
$38.84
NEUP
+54.07%
$6.24
ADTX
-28.06%
$0.21
PLUG
+2.43%
$2.95
T
+2.11%
$25.14
RIG
+0.25%
$3.90
SCNX
-39.61%
$1.57
NOK
+2.10%
$6.30
AMD
+7.63%
$252.92
QBTS
+5.11%
$32.65
AXDX
-61.36%
$0.03
ABEV
-0.90%
$2.19
GPUS
+4.19%
$0.40
WTO
-7.14%
$0.06
RF
+1.95%
$24.57
CAN
+7.38%
$1.89
LAES
+22.55%
$7.01
SOFI
+3.31%
$29.01
NEHC
+48.35%
$5.86
NUAI
+48.35%
$5.86
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
GRAB
+2.27%
$5.85
TLRY
+0.67%
$1.49
QS
+14.73%
$16.82
ADAP
-7.57%
$0.06
SNAP
+1.01%
$7.95
CIFR
+19.73%
$20.66
AIRE
-22.42%
$0.76
ETHD
-3.52%
$3.83
JOBY
+2.93%
$16.13
ACHR
+3.48%
$11.29
IONZ
-4.02%
$3.82
RMBL
+60.50%
$3.21
RXRX
+5.41%
$6.04
BAC
+1.56%
$52.57
AMZN
+1.41%
$224.21
NIO
+0.14%
$6.90
AAPL
+1.24%
$262.82
ADD
-25.47%
$0.05
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
BTBT
+5.10%
$3.91
RR
+12.17%
$6.08
AMC
-1.46%
$2.69
NVTS
+3.37%
$14.07
SRM
+53.27%
$10.30
PLTR
+2.29%
$184.63
CLOV
+19.37%
$3.82
UUUU
+0.51%
$21.37
BTG
-0.38%
$5.21
DFLI
+13.27%
$1.28
RVPH
+18.99%
$0.67
BBD
0.00%
$3.35
MARA
+1.66%
$19.54
KDLY
+5.66%
$0.84
NAKA
+5.66%
$0.84
APLD
+0.14%
$33.43
CUTR
-10.19%
$0.09
PBR
-0.84%
$11.74
WU
+10.19%
$8.97
GOOGL
+2.70%
$259.92
SOUN
-1.42%
$17.98
WLGS
-5.57%
$0.04
RIVN
-0.84%
$12.98
IONQ
+1.56%
$60.30
VZ
+1.09%
$38.82
PFE
+0.36%
$24.76
WULF
+6.44%
$13.71
LAZR
+31.36%
$2.22
ETWO
0.00%
$3.30
RGTZ
+3.08%
$15.36
SKYQ
+9.15%
$0.50
MU
+5.95%
$219.02
JBLU
0.00%
$4.57
SMCI
+0.77%
$48.29
CLSK
+9.59%
$19.36
WBD
-0.47%
$21.15
LUMN
+3.85%
$8.09
HOOD
+4.06%
$139.79
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.